VEGFA and myocardial infarction: Previous studies have shown that erythropoietin combined with granulocyte-colony-stimulating factor can enhance vascular formation and reduce infarct area after bone marrow stem cell transplantation in myocardial infarction area by increasing endothelial progenitor cell mobilization and up-regulating vascular endothelial growth factor and other microenvironments [11].